Phase II trial of (177)lutetium radiolabeled anti-prostate-specific membrane antigen (PSMA) monoclonal antibody J591 (Lu-177-J591) in patients (PTS) with metastatic castrate-resistant prostate cancer (metCRPC) Meeting Abstract
| Authors: | Tagawa, S. T.; Jeske, S.; Milowsky, M. I.; Vallabhajosula, S.; Goldsmith, S.; Matulich, D.; Kaplan, J.; Bander, N. H.; Nanus, D. M. |
| Abstract Title: | Phase II trial of (177)lutetium radiolabeled anti-prostate-specific membrane antigen (PSMA) monoclonal antibody J591 (Lu-177-J591) in patients (PTS) with metastatic castrate-resistant prostate cancer (metCRPC) |
| Meeting Title: | 12th Conference on Cancer Therapy with Antibodies and Immunoconjugates |
| Journal Title: | Cancer Biotherapy and Radiopharmaceuticals |
| Volume: | 23 |
| Issue: | 4 |
| Meeting Dates: | 2008 Oct 16-18 |
| Meeting Location: | Parsippany, NJ |
| ISSN: | 1084-9785 |
| Publisher: | Mary Ann Liebert, Inc |
| Date Published: | 2008-08-01 |
| Start Page: | 525 |
| Language: | English |
| ACCESSION: | WOS:000259167300048 |
| PROVIDER: | wos |
| DOI: | 10.1089/cbr.2008.12Conf-3 |
| Notes: | --- - Meeting Abstract: 36 - 12th Conference on Cancer Therapy with Antibodies and Immunoconjugates - OCT 16-18, 2008 - Parsippany, NJ - "Source: Wos" |
